Patient characteristics
This retrospective study included all patients who underwent transmediastinal esophagectomy for esophageal cancer at the Tsukuba University Hospital from 2018 to 2021. We excluded patients who had a history of lung surgery, converted to thoracotomy, developed pneumothorax, and required tube drainage at the time of wound closure, underwent simultaneous surgery for a second cancer, or whose gastric conduit could not be used.
Procedure
All patients underwent transcervical, transmediastinal esophagectomy with radical lymph node dissection, followed by the laparoscopic transhiatal approach, as described previously [2, 3]. In almost all patients, abdominal and transhiatal procedures were performed laparoscopically; in seven patients, the procedures were hand-assisted. In this study, patients were divided into two groups, namely the with or without transhiatal chest drainage groups. In the drainage group, the transhiatal left chest drainage tube was placed after esophagectomy and lymph node dissection; the drainage tube was inserted from the inferior hepatic space to the left thoracic cavity blindly through the hiatus by intentional left pleural incision before hiatal closure (Figs. 1 and 2). In the non-drainage group, the pleura was preserved, and the hiatus was closed directly. We used a 19-Fr Blake® (Ethicon, Inc., Somerville, NJ, USA) drain connected to a portable vacuum system (J-Vac®; Ethicon). Reconstruction was performed using a gastric conduit via the retrosternal route with cervical anastomosis. Transhiatal chest drainage, introduced in February 2020, has been used in all patients since. Using the immediate postoperative radiograph (Fig. 3), patients were assigned to the drainage and non-drainage groups.
To assess the effectiveness and safety of transhiatal chest drainage, the primary outcome measure was daily drainage output and the accumulation of postoperative pleural effusion. The secondary outcome was the frequency of postoperative thoracentesis and other complications. Chest radiography was performed everyday until postoperative day 5 to evaluate the accumulation of pleural effusion. The indication for postoperative thoracentesis was the accumulation of pleural effusion, which was diagnosed by radiography and required oxygen administration. Thoracentesis was avoided for patients who could not be punctured safely on ultrasonography. The other following data were collected from the clinical database: age, sex, body mass index (BMI), tumor location, and T stage based on the 7th edition of the AJCC/UICC TNM classification system [7], lymph node metastasis status, histological type, neoadjuvant chemotherapy, operation time, blood loss volume, number of dissected lymph node, frequency of postoperative thoracentesis and its complications, drained volume of pleural effusion, occurrence of postoperative complications (grade 3 or more) based on the Clavien–Dindo classification [8], duration of oxygen administration, percentage of body weight loss on postoperative day (POD) 14, and duration of postoperative hospital stay. In the drainage group, the procedure time to insert the transhiatal drainage tube was measured. The study’s retrospective protocol was approved by our institutional review board (No. R1-017), and written informed consent for publication was obtained from the patients.
Statistical analysis
Comparisons between the drainage and non-drainage groups were performed using the chi-square test for categorical variables (sex, tumor location, T stage, lymph node metastasis, histological type, and occurrence of postoperative complications) and the Mann–Whitney U test for continuous variables (age, BMI, operation duration, blood loss volume, number of dissected lymph nodes, duration of oxygen administration, and postoperative hospital stay). All analyses were performed using IBM SPSS Statistics for Windows version 25.0 (IBM Corp., Armonk, NY, USA). P-values <0.05 were considered statistically significant.